John G Ullman & Associates Inc. Sells 100 Shares of Abbott Laboratories (NYSE:ABT)
John G Ullman & Associates Inc. decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 30,844 shares of the healthcare product maker’s stock after selling 100 shares during the quarter. John G Ullman & Associates Inc.’s holdings in Abbott Laboratories were worth $3,363,000 […]
More Stories
Cormark Has Negative Forecast for Orla Mining Q2 Earnings
Orla Mining Ltd. (TSE:OLA – Free Report) – Equities researchers at Cormark lowered their Q2 2025 earnings per share (EPS)...
Q2 Earnings Forecast for CRC Issued By Capital One Financial
California Resources Co. (NYSE:CRC – Free Report) – Equities researchers at Capital One Financial decreased their Q2 2025 earnings per...
Top Cloud Storage Stocks To Follow Now – April 16th
NetApp, Commvault Systems, and Alarm.com are the three Cloud Storage stocks to watch today, according to MarketBeat’s stock screener tool....
Seaport Res Ptn Has Negative Outlook for GS Q2 Earnings
The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) – Equities researchers at Seaport Res Ptn decreased their Q2 2025...
Q2 EPS Estimates for AXIS Capital Raised by Zacks Research
AXIS Capital Holdings Limited (NYSE:AXS – Free Report) – Equities researchers at Zacks Research raised their Q2 2025 EPS estimates...
Atb Cap Markets Has Negative Estimate for GFL Q2 Earnings
GFL Environmental Inc. (NYSE:GFL – Free Report) – Analysts at Atb Cap Markets dropped their Q2 2025 earnings estimates for...